B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 59 CAD 4.8%
Market Cap: 263.4m CAD
Have any thoughts about
Bright Minds Biosciences Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Bright Minds Biosciences Inc

Rotate your device to view
Cash Flow Statement
Currency: CAD
Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
(9)
(13)
(16)
(15)
(15)
(12)
(10)
(9)
(7)
(7)
(5)
(4)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
1
1
1
1
1
1
1
1
1
1
1
1
Change in Working Capital
1
1
1
0
1
0
(0)
0
(1)
0
(0)
(0)
Cash from Operating Activities
(7)
N/A
(12)
-60%
(14)
-19%
(14)
+1%
(14)
+2%
(11)
+17%
(9)
+19%
(8)
+13%
(7)
+12%
(5)
+26%
(4)
+14%
(3)
+42%
Investing Cash Flow
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
28
26
0
0
6
8
8
8
2
1
1
1
Net Issuance of Debt
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other
(2)
(2)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
0
0
0
Cash from Financing Activities
26
N/A
24
-7%
(0)
N/A
0
N/A
5
+4 151%
7
+41%
7
0%
7
0%
2
-70%
1
-63%
1
0%
1
0%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
Net Change in Cash
19
N/A
13
-32%
(14)
N/A
(13)
+4%
(8)
+39%
(4)
+52%
(2)
+54%
(1)
+72%
(5)
-856%
(4)
+9%
(4)
+16%
(2)
+48%
Free Cash Flow
Free Cash Flow
(7)
N/A
(12)
-60%
(14)
-19%
(14)
+1%
(14)
+2%
(11)
+17%
(9)
+19%
(8)
+13%
(7)
+12%
(5)
+26%
(4)
+14%
(3)
+42%

See Also

Discover More